BBSC Among Small Cap ETFs
End-of-day Nov 20, 2026 · 97 Small cap ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −3.2% | −7.6% | −6.9% | −12.5% | +7.5% | +13.4% | +52.6% | +20.3% | — | +66.0% |
| Peer average | −2.3% | −6.5% | −6.1% | −9.7% | +8.7% | +14.8% | +44.7% | +21.2% | +149.7% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$5 of every $1,000 in BBSC is Jfrog
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | —Jpmorgan U.s. Government | — | 0.94% | $93.82 | 6.6M | $6.6M |
| 2 | FROGJfrog | Technology | 0.48% | $48.26 | 31K | $3.4M |
| 3 | AHRAmerican Healthcare Reit | Real Estate | 0.47% | $47.47 | 58K | $3.3M |
| 4 | BTSGBrightspring Health | Healthcare | 0.42% | $41.51 | 46K | $2.9M |
| 5 | SMTCSemtech | Technology | 0.41% | $40.68 | 28K | $2.9M |
| 6 | MOG-AMoog | Industrials | 0.40% | $39.95 | 8,588 | $2.8M |
| 7 | EATBrinker International | Consumer Cyclical | 0.35% | $35.27 | 13K | $2.5M |
| 8 | KRYSKrystal Biotech | Healthcare | 0.35% | $34.99 | 7,815 | $2.5M |
| 9 | CTRECaretrust Reit Reit | Real Estate | 0.35% | $34.53 | 66K | $2.4M |
| 10 | SSentinelone | Technology | 0.34% | $33.78 | 99K | $2.4M |
| 11 | SYRESpyre Therapeutics | Healthcare | 0.32% | $32.49 | 23K | $2.3M |
| 12 | CROXCrocs | Consumer Cyclical | 0.32% | $32.12 | 14K | $2.3M |
| 13 | RALRalliant | Technology | 0.32% | $31.75 | 34K | $2.2M |
| 14 | ZETAZETA Global | Technology | 0.31% | $31.06 | 68K | $2.2M |
| 15 | COMPCompass | Real Estate | 0.30% | $30.22 | 214K | $2.1M |
of the $573B in 112 Small cap ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | FROG | Jfrog | 0.48% |
| 2 | AHR | American Healthcare Reit | 0.47% |
| 3 | BTSG | Brightspring Health | 0.42% |
| 4 | SMTC | Semtech | 0.41% |
| 5 | MOG-A | Moog - | 0.40% |
| 6 | EAT | Brinker International | 0.35% |
| 7 | KRYS | Krystal Biotech | 0.35% |
| 8 | CTRE | Caretrust Reit Reit | 0.35% |
| 9 | S | Sentinelone | 0.34% |
| 10 | SYRE | Spyre Therapeutics | 0.32% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 22, 2026 | Sep 24, 2026 | $0.25 |
| Jun 23, 2026 | Jun 25, 2026 | $0.19 |
| Mar 24, 2026 | Mar 26, 2026 | $0.17 |
| Dec 23, 2025 | Dec 26, 2025 | $0.31 |
| Sep 23, 2025 | Sep 25, 2025 | $0.24 |
| Jun 24, 2025 | Jun 26, 2025 | $0.17 |
| Mar 25, 2025 | Mar 27, 2025 | $0.12 |
| Dec 24, 2024 | Dec 27, 2024 | $0.34 |
| Sep 24, 2024 | Sep 26, 2024 | $0.20 |
| Jun 25, 2024 | Jun 27, 2024 | $0.18 |
| Mar 19, 2024 | Mar 22, 2024 | $0.15 |
| Dec 19, 2023 | Dec 22, 2023 | $0.36 |